Forgot your password?

Forgot your username?

DATABASE UPDATES
  • AMT BioPharma     The Netherlands  |  Developer of innovative treatments using gene therapy.
  • NanoViricides, Inc.    West Haven, CT  |  Anti-viral drugs to fight HIV, influenza, and other infections
  • Urovalve    Newark, NJ  |  Developer of patented technology to control fluid flow through...
  • Tolera Therapeutics    Kalamazoo, MI  |  T-Cell Modulation for Treatment of Autoimmune Disorders, Transplant
  • CorInnova Incorporated    Houston, TX  |  Breakthrough Device for Cardiac Assist and Recovery: CorInnova is developing...
  • PCAsso Diagnostics LLC      |  Developing the next generation contrast agents.
  • BioNanomatrix, Inc.    Philadelphia, PA  |  Develops single-molecule analysis systems for applications in molecular biology,...
NEWS
BREAKING NEWS: Advaxis Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer
January 26 2012
Advaxis is a clinical-stage biotechnology company developing the next generation of immunotherapies.


S.E.A. Medical Secures $3 Million in Series B Financing from JK&B Capital
January 26 2012
Healthtech company makes strides towards developing medical devices designed to catch life-threatening IV drug errors before they harm patients


Provectus Receives Guidance From FDA On Pathway to Approval for Phase 3 Trial of PV-10 For Metastatic Melanoma
January 25 2012
Dr. Craig Dees talks candidly in a live audio interview about the company’s developments.


This Week In Diagnostics
January 24 2012
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.


Partners & Sponsors